2-naphthol has been researched along with Atherogenesis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brissette, L; Bujold, K; Febbraio, M; Marleau, S; Mellal, K; Ong, H; Rhainds, D; Zoccal, KF | 1 |
1 other study(ies) available for 2-naphthol and Atherogenesis
Article | Year |
---|---|
EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; CD36 Antigens; Cells, Cultured; Cholesterol; Disease Models, Animal; Female; Intestinal Absorption; Lipoproteins; Liver; Liver X Receptors; Macrophages; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthols; Oligopeptides; Orphan Nuclear Receptors; RNA, Messenger; Triazines | 2013 |